Nascent Iodine vs. Iodoral
Numerous questions have been raised about the differences between Iodoral and Nascent Iodine. In early 2010, the question was posed to me about which is better. After some extensive research I will attempt to define the clinical features of these two iodine products as I see them and their individual advantages. Personally I like both products for different reasons.
No Studies for direct comparison -
At the time of this writing, I have found no formal, or significant informal, head to head studies comparing these two products. This means that only scientific argument, clinical opinion and personal experience remain for analysis.
High dose vs. Low dose -
All high dose
studies have been done using Iodoral or comparative formulations.
1) Proponents of Nascent Iodine
usually focus on low dose therapy and the claim of enhanced
bioavailability. Usually the only studies referenced to are those
used to establish the RDA recommendations.
2) Proponents of Lugol's solution or Iodoral usually focus on the benefits of high dose therapy and
the well conducted clinical data to back the position. Please see
the references listed on our
site under
Iodine Research. These
benefits include the detoxification of halides and heavy metals.
Mostly historical data is on
iodine and potassium iodide.
Absorption -
Studies on Iodoral are clear. On average nearly 99% of the dose is absorbed. The absorption rate between the two products could be easily studied with existing technology, but no such studies have yet been conducted. In theory tough, they both should have near equal oral absorption rates as iodine in all its natural forms is very well absorbed orally.
Bioavailability -
Bioavailability is about how much of a nutrient is available for use after absorption compared to how much is not. I believe that the claim of increased bioavailability of Nascent Iodine does have merit, and does make sense from the scientific perspective of the molecular state of Nascent iodine. If Nascent is indeed more bioavailable, I doubt that the scale of difference between recommended doses, 2-4mg for Nascent compared to 12.5-50mg for Iodoral, bears out. Clinically, I have seen faster symptomatic responses to Nascent Iodine, but only when dosed similarly to the 50mg per day evidenced by the research done by Iodoral proponents.
Proper Dosage -
The rational for dosage of iodine therapy differs based on one's
goal and Ideology.
1) The minimum needed to sustain life and prevent
goiter (ex. RDA of 1-2mg per day).
2) What is necessary for healthy maintenance
(12-12.5mg/day). This number is derived from demographical research
concerning iodine related disease incidence from cultures where
iodine content is high in the diet compared to cultures with low
dietary iodine. Please see references.
3) Overcoming competitive inhibition. The real
issues lie in pollutants that compete for iodine's place in the
body, known as competitive displacement or inhibition. Chemicals &
elements such as fluoride, bromide, other halides, mercury, lead,
aluminum and more can displace iodine from it's place in the body.
The reverse is also true. Iodine can displace these substances if
sufficient quantities are present to get ahead of the curve. To
date, 50mg is to most common target dose that elicits this shift in
balance and begins the dumping of these toxic elements, restoring
symptomatic patients to better health. This number could change if
pollution levels should rise or fall. Such instances requiring
higher doses are being seen in my clinic as well as other iodine
specializing clinics around the world. And upon occasion, I will see
a case that requires less. On balance the 50mg target dose seems to
be the appropriate dose for 98% of my clients on iodine therapy.
Tolerance & Personal Experience -
Both products are well tolerated in most cases. Even patients with iodine allergy will on average tolerate either product well. Cases that react poorly to oral administration often benefit from transdermal supplementation without reaction. I prefer Nascent Iodine over simple iodine tincture in transdermal applications. I also prefer Nascent iodine if there is a history of iodine sensitivity, as it seems to produce less allergic reactions orally in my experience. Iodoral has become a very popular product that is well studied, and I still use it in a vast majority of my clients with great success since 2005. Its ease of administration is often a significant plus and is the gold standard in high dose iodine therapy.
Which one should you choose -
Both products
have their own individual merits and selecting a product should be
based on your own unique situation and preferences. You should consult with an iodine literate professional when making the
decision to begin iodine therapy of any kind. Dr. Kassner is
available to assist you with a phone
consultation if you should desire.
Iodoral
provides a simple tablet for high dose oral administration and is
very well researched. Its benefits and potential complications are
well documented and iodine literate physicians have the most
experience dealing with Iodoral. While
Nascent is
excellent in sensitive cases where transdermal or very tight dosage
control is needed. Nascent may also provide a slightly faster
clinical result.
Transdermal Iodine -
Transdermal application of iodine is the most inefficient method of delivery with only 1-4% of the total dose absorbed into circulation. Iodine is a volatile element subject to evaporation at typical room and body temperatures. 75-85% of transdermally applied iodine is lost to evaporation. So if you go with transdermal application, do so as a last choice. The application of a heavy cream or Vaseline over the iodine patch may slow down the evaporation and possibly increase absorption.